Literature DB >> 21293157

Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity.

Miho Nagai1, Kouichi Hirayama, Itaru Ebihara, Homare Shimohata, Masaki Kobayashi, Akio Koyama.   

Abstract

BACKGROUND: A proliferation-inducing ligand (APRIL) and the B cell activation factor belonging to the tumor necrosis factor family (BAFF) have proven to be key factors in the selection and survival of B cells, and a higher concentration of BAFF has been shown to contribute to autoreactive B cell survival and elevated autoantibody production. Here, serum BAFF and APRIL levels were investigated to analyze their association with disease activity in myeloperoxidase anti-neutrophil cytoplasmic autoantibody (MPO-ANCA)-associated renal vasculitis.
METHODS: APRIL and BAFF levels in serum obtained from 37 patients with MPO-ANCA-associated vasculitis were measured by ELISA. Samples were taken from active vasculitis patients, inactive vasculitis patients and inactive vasculitis patients with infectious complications.
RESULTS: Although there was no difference in serum APRIL among the active vasculitis, inactive vasculitis and infectious complication patients, serum BAFF was higher in active vasculitis patients than in inactive vasculitis, infectious complication and control patients (for all, p < 0.001). There was no significant correlation between serum APRIL and ANCA titers, but there was a significant correlation between serum BAFF and ANCA titers (r = 0.465, p < 0.001).
CONCLUSION: Excessive BAFF production in MPO-ANCA-associated vasculitis may be one of the factors for autoimmune B cell tolerance, resulting in MPO-ANCA production.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21293157     DOI: 10.1159/000323393

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  21 in total

Review 1.  B Cells, Antibodies, and More.

Authors:  William Hoffman; Fadi G Lakkis; Geetha Chalasani
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 8.237

2.  Serum soluble levels of the transmembrane activator and calcium-modulator and cyclophilin-ligand interactor in MPO-ANCA-associated renal vasculitis.

Authors:  Miho Nagai; Kouichi Hirayama; Itaru Ebihara; Masaki Kobayashi
Journal:  Clin Exp Nephrol       Date:  2015-01-08       Impact factor: 2.801

3.  Increased BAFF expression in nasal polyps is associated with local IgE production, Th2 response and concomitant asthma.

Authors:  Yan Zheng; Zhuofu Liu; Xianting Hu; Jia Zhang; Li Hu; Miaomiao Han; Dehui Wang; Huabin Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-29       Impact factor: 2.503

Review 4.  Targeting B Cells and Plasma Cells in Glomerular Diseases: Translational Perspectives.

Authors:  Eva Schrezenmeier; David Jayne; Thomas Dörner
Journal:  J Am Soc Nephrol       Date:  2018-01-11       Impact factor: 10.121

Review 5.  Biomarkers in ANCA-Associated Vasculitis: Potential Pitfalls and Future Prospects.

Authors:  Adam D Morris; Anthony W Rowbottom; Francis L Martin; Alexander Woywodt; Ajay P Dhaygude
Journal:  Kidney360       Date:  2021-01-19

Review 6.  B cell-mediated pathogenesis of ANCA-mediated vasculitis.

Authors:  J Charles Jennette; Ronald J Falk
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

Review 7.  Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease.

Authors:  J Charles Jennette; Ronald J Falk
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

8.  Cerebrospinal fluid biomarkers implicated in the pathogenesis of anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis.

Authors:  Junji Ikeda; Yasuhiro Shimojima; Yoko Usami; Ken-Ichi Ueno; Dai Kishida; Yoshiki Sekijima
Journal:  Clin Rheumatol       Date:  2020-02-08       Impact factor: 2.980

9.  Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome.

Authors:  Karin Kannel; Kristi Alnek; Liina Vahter; Katrin Gross-Paju; Raivo Uibo; Kalle V Kisand
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

Review 10.  Targeting dendritic cell function during systemic autoimmunity to restore tolerance.

Authors:  Juan P Mackern-Oberti; Fabián Vega; Carolina Llanos; Susan M Bueno; Alexis M Kalergis
Journal:  Int J Mol Sci       Date:  2014-09-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.